Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
546
datasets available to search
ShareScore release 0.9.0
Dataset results
546 results for “Predictive biomarkers”
Predictive Value of Inflammatory Biomarkers and FEV1 for COPD
ClinicalTrials.gov study NCT03532893. IPD Sharing: NO. Countries: 1. Publications: 4.
Biomarkers in Prediction of AMI
ClinicalTrials.gov study NCT06212921. IPD Sharing: NO. Countries: 2. Publications: 1.
cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT07224815. IPD Sharing: NO. Countries: 1. Publications: 17.
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
ClinicalTrials.gov study NCT02871895. IPD Sharing: UNDECIDED. Countries: 1. Publications: 12.
The Value of Infectious Biomarkers for Prediction of Complication After Hepatopancreatobiliary Surgery
ClinicalTrials.gov study NCT02878668. IPD Sharing: UNDECIDED. Countries: 1. Publications: 10.
A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
ClinicalTrials.gov study NCT03047616. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates
ClinicalTrials.gov study NCT02637817. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Predictive biomarkers of individual trajectories in elderly persons with subtle cognitive decline: APOE genotype data
Open the record for dataset details and reuse information.
Data from: Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma
Open the record for dataset details and reuse information.
Data from: Characteristics of patients included and enrolled in studies on the prognostic value of serum biomarkers for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review
Objective: Mild traumatic brain injury (mTBI) has been insufficiently researched and its definition remains elusive. Investigators are confronted by heterogeneity in patients, mechanism of injury and outcomes. Findings are thus often limited in generalizability and clinical application. Serum protein biomarkers are increasingly assessed to enhance prognostication of outcomes but their translation into clinical practice has yet to be achieved. A systematic review was performed to describe the adult populations included and enrolled in studies that evaluated the prognostic value of protein biomarkers to predict post-concussion symptoms following a mTBI. Data sources: Searches of MEDLINE, EMBASE, CENTRAL, CINAHL, Web of Science, PsycBITE, and PsycINFO up to October 2016. Data selection and extraction: Two reviewers independently screened for potentially eligible studies, extracted data and assessed the overall quality of evidence by outcome using the Grading of Recommendations Assessment, Development and Evaluation approach. Results: A total of 23,298 citations were obtained from which 166 manuscripts were reviewed. Thirty-six cohort studies (2,812 patients) having enrolled between 7 and 311 patients (median 89) fulfilled our inclusion criteria. Most studies excluded patients based on advanced age (n=10 (28%)), neurologic disorders (n=20 (56%)), psychiatric disorders (n=17 (47%)), substance abuse disorders (n=13 (36%)) or previous TBI (n=10 (28%)). Twenty-one studies (58%) used at least two of these exclusion criteria. The pooled mean age of included patients was 39.3 (SD 4.6) years old (34 studies). The criteria used to define a mTBI were inconsistent. The most frequently reported outcome was post-concussion syndrome (PCS) using the Rivermead Post-Concussion Symptoms Questionnaire (n=18 (50%)) with follow-ups ranging from 7 days to 5 years after the mTBI. Conclusions: Most studies have recruited samples that are not representative and generalizable to the mTBI population. These exclusion criteria limit the potential use and translation of promising serum protein biomarkers to predict post-concussion symptoms.
Data from: Small RNAs in rat sperm are a predictive and sensitive biomarker of exposure to the testicular toxicant ethylene glycol monomethyl ether.
Testicular histology and semen parameters are considered the gold standards when determining male reproductive toxicity. Ethylene glycol monomethyl ether (EGME) is a testicular toxicant with well-described effects on histopathology and sperm parameters. To compare the predictivity and sensitivity of molecular biomarkers of testicular toxicity to the traditional endpoints, small RNAs in the sperm were analyzed by next generation RNA-sequencing (RNA-seq). Adult rats were exposed to 0, 50, 60, or 75 mg/kg EGME by oral gavage for 5 consecutive days. Testis histology, epididymal sperm motility and sperm small RNAs, including microRNAs (miRNAs), mRNA fragments, piwi-associated RNAs (piRNAs), and tRNA fragments (tRFs), were analyzed 5 weeks after cessation of exposure. Testicular histology showed a significant dose-dependent increase in retained spermatid heads (RSH), while sperm motility declined with increasing dose. RNA-seq of sperm small RNAs was used to identify significant dose-dependent changes in percent mRNA fragments (of total reads), percent miRNAs (of total reads), average tRF length, average piRNA length, and piRNA and tRF length-distributions. Discriminant analysis showed relatively low predictivity of treatment based on RSH or motility compared to the average read length of all aligned RNAs. Benchmark dose (BMD) modeling resulted in a BMD of 62 mg/kg using RSH, whereas average read length of all aligned RNAs resulted in a BMD of 47 mg/kg. These results showed that sperm small RNAs are sensitive and predictive biomarkers of EGME-induced male reproductive toxicity.
Figure 1 from: Rane S, Jolly E, Park A, Jang H, Craddock C (2017) Developing predictive imaging biomarkers using whole-brain classifiers: Application to the ABIDE I dataset. Research Ideas and Outcomes 3: e12733. https://doi.org/10.3897/rio.3.e12733
Figure 1 - Weights (β-coefficients) for voxel-wise ReHo features from a support vector machine (SVM) classifier mapped on the glass brain to separate individuals with and without Autism Spectrum Disorder
A case study: assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data
Open the record for dataset details and reuse information.
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
ClinicalTrials.gov study NCT01074398. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases
ClinicalTrials.gov study NCT02179047. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
ClinicalTrials.gov study NCT03573791. IPD Sharing: NO. Countries: 1. Publications: 0.
Methylated Biomarkers Predictive of Endometrial Cancer Risk
ClinicalTrials.gov study NCT06800677. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD
ClinicalTrials.gov study NCT05829681. IPD Sharing: YES. Countries: 1. Publications: 0.
Validating a Brief Screening Tool With Biomarkers for Prediction of Chronic Post Traumatic Neck Pain
ClinicalTrials.gov study NCT06176209. IPD Sharing: NO. Countries: 0. Publications: 1.
Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer
ClinicalTrials.gov study NCT00773773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.